Hereditary Cancer Genetic Testing
Family History Questionnaire
Designed to help your patients assess their risk of hereditary cancer. For more information on how to implement this questionnaire within your practice, our customer service team is happy to help. Call us directly at 888-729-1206 (option 3), or email email@example.com.
Pre-test educational video
If you believe that a hereditary cancer test is right for your patient, you may ask your patient to watch this informational video to learn more about the testing process.
Want to get involved?
The convenient kit below includes the Patient Information Card, social media posts, and email templates customizable for your practice so patients can:
- Understand the importance of knowing their hereditary cancer risk
- Learn how your practice can help support their care
- Take steps to understand if hereditary cancer testing may be appropriate for them
How to choose the right kit
to fit your needs
If you would like to use GeneScreen (GS), a genetic counseling service that will be available to your patients after they complete their Hereditary Cancer Family History Questionnaire. If you already have in-house genetic counseling, please download the Non-GS kit instead.
1. ACOG Hereditary Cancer Syndromes and Risk Assessment. ACOG COMMITTEE OPINION SUMMARY, Number 793. Obstetrics & Gynecology: December 2019 – Volume 134 – Issue 6 – p 1366-1367.; 2. Lindsay Dohany, et al. Hereditary cancer risk assessment using a chatbot in women presenting to obstetrics and gynecology practices across the U.S. [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P6-08-39.; 3. Frezzo, T., et al. The genetic family history as a risk assessment tool in internal medicine. Genet Med 5, 84–91 (2003).; 4. DeFrancesco MS, et al. Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting. Obstet Gynecol. 2018 Nov;132(5):1121-1129.; 5. The National Cancer Institute: The Genetics of Cancer. August 17, 2022; 6. Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017 May 15;123(10):1721-1730.; 7. Walsh T., Casadei S., Lee M. K., et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(44):18032–18037.; 8. Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005;104:2807–16.